Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-07-29, Stock:ABBV, The news for the past five days is as follows:
2020-07-22: NEWS1: AbbVie's Rinvoq Meets Late-Stage Eczema Study Endpoints.NEWS2: Is AbbVie a Great Dividend Stock?.
2020-07-23: NEWS1: 3 Strong Dividend Stocks to Buy Now for Income & Coronavirus Growth.
2020-07-24: NEWS1: AbbVie Proves Masterful at Playing Drug Patent Game.NEWS2: Trump signs executive order aimed at lowering drug prices.NEWS3: 5 High-Yield Drug Stocks That Are Undervalued With Great Upside.NEWS4: Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for.
2020-07-27: NEWS1: What Lies Ahead for Healthcare ETFs in Q2 Earnings?.NEWS2: Has AbbVie (ABBV) Outpaced Other Medical Stocks This Year?.NEWS3: How Damaging Will Coronavirus be for AbbVie (ABBV) Q2 Earnings?.
2020-07-28: NEWS1: Novo, Roche Scored Highest Returns on Invested Capital.NEWS2: Why the Earnings Surprise Streak Could Continue for AbbVie (ABBV).NEWS3: Will Humira, Cancer Drugs Drive AbbVie (ABBV) Q2 Earnings?.NEWS4: Third Pivotal Phase 3 Study Shows RINVOQ™ (upadacitinib) Plus Topical Corticosteroids Improves Skin and Itch Symptoms in Atopic Dermatitis Patients.

Answer: Rise